Kora Healthcare logo

Health Professional Products

Magnaspartate

Magnaspartate

Magnaspartate® is an oral magnesium powder supplement indicated for the dietary management of magnesium deficiency.
Magnaspartate® (Magnesium-L-aspartate.2H20) provides magnesium in a highly soluble bioavailable salt form.
Magnaspartate® is supplied in easy-to-use single dose 6.5 g sachets (pre-measured sachets) each containing Magnesium-L-aspartate.2H20 equivalent to 243.12 mg (10 mmol) (3.74 g Magnesium per 100 g).

More Information

Each 6.5 g sachet of Magnaspartate® contains 81% of the Recommended Daily Allowance (RDA) for Magnesium in healthy adults.

Each Magnaspartate® sachet can be dissolved in 50-200 mL water and has a peach/apricot flavour. Solubility, however, is reduced at 50 mL or less1.

The osmolality of 1 sachet of Magnaspartate® in 200 mL of water is 168 mOsm/L.
Magnaspartate® is a Food for Special Medical Purposes (FSMP) and can be prescribed on FP-10, GP-10 and WP-10 forms.
Magnaspartate® has a shelf life of 2 years.
Hypomagnesaemia (magnesium deficiency) may occur in a range of conditions such as:-
  • Intestinal failure and malabsorption disorders
  • Short bowel syndrome
  • Crohn’s disease
  • Post organ transplantation
  • Refeeding syndrome
  • Post chemotherapy induced magnesium loss
  • Post bone marrow transplantation
  • Metabolic disorders
Magnaspartate Solubility
The Magnesium salt in Magnaspartate, Magnesium-L-aspartate.2H20, is 10 times more soluble than Magnesium glycerophosphate and 1000 times more soluble than Magnesium oxide2.
Organic salts of magnesium such as Magnesium-L-aspartate have the greatest water solubility and demonstrate a greater oral absorption and bioavailability compared to other less soluble magnesium preparations such as Magnesium oxide, Magnesium hydroxide, Magnesium carbonate and Magnesium sulphate3.
A study in patients with short bowel syndrome compared the effects of Magnesium plasma levels of patients receiving oral Magnesium-L-aspartate supplementation with those receiving a combination of intravenous Magnesium and oral Magnesium glycerophosphate. The study concluded that oral Magnesium-L-aspartate supplementation may be an effective way of treating hypomagnesaemia in patients with short bowel syndrome4.
Magnaspartate Dosage
For Adults: Dissolve the contents of 1 sachet (6.5 g) in approx. 200 mL water and take orally once daily.
For Children (2-10 years): Dissolve the contents of 1 sachet (6.5 g) in approx. 200 mL water and take half the solution orally once daily (dispose of the remaining 100 mL).
Magnaspartate® can be sourced from all UK wholesalers.
Magnaspartate® PIP Code: 311-9203 EAN Number: 5099442003484
Important Notice
Magnaspartate® is to be used under medical supervision.
Magnaspartate® is not suitable as a sole source of nutrition.
Magnaspartate® is not suitable for children under 2 years of age.
Magnaspartate® is not suitable for parenteral use.
Further Information
Click here for the Magnaspartate Information Booklet

For further information and samples of Magnaspartate®, please contact us by clicking here.

1 KoRa Healthcare (2006) Internal Report

2 KoRa Healthcare (2006) Internal Report

3 The Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (2005) Magnesium Aspartate as a mineral substance in when used as a source of magnesium in dietary food for special medical purposes, The EFSA Journal, 167, 1-6

4 P.Turner, V. Mishra, E.M.C Marks (2007) Effect of Magnesium-L-Aspartate Supplementation on the plasma magnesium levels in patients with short bowel syndrome. Clinical Nutritional Supplements, 2,3 - 161